TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36078607

Group type: EXPERIMENTAL
Intervention: Environmental exposures (drinking water source, sanitation, exposure to animals, housing materials, season, residential area, food insecurity)
Number of subjects: 620
Study: 33542479

Group type: EXPERIMENTAL
Intervention: Blinatumomab (9 μg/day cycle 1 week 1, 28 μg/day thereafter for 4 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blinatumomab or Chemotherapy (both groups)
Number of subjects: 0
Study: 36469441

Group type: EXPERIMENTAL
Intervention: Oral gavage (OG) administration of terbinafine (30 mg/kg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Bioencapsulated (BEC) administration of terbinafine (30 mg/kg)
Number of subjects: 7
Study: 34002564

Group type: EXPERIMENTAL
Intervention: Wheat grain moxibustion
Number of subjects: 200

Group type: COMPARATOR
Intervention: Warming acupuncture
Number of subjects: 200
Study: 32557180

Group type: EXPERIMENTAL
Intervention: Positive framing with natural frequencies
Number of subjects: 1067

Group type: EXPERIMENTAL
Intervention: Positive framing with percentages
Number of subjects: 1067

Group type: COMPARATOR
Intervention: Current practice PIL
Number of subjects: 1067
Study: 36260424

Group type: EXPERIMENTAL
Intervention: Mathlete (experimental group, 30 children)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Traditional teaching (control group, 10 children)
Number of subjects: 40
Study: 33450081

Group type: EXPERIMENTAL
Intervention: omega-3 FAs
Number of subjects: 90

Group type: COMPARATOR
Intervention: omega-6 FAs
Number of subjects: 90

Group type: COMPARATOR
Intervention: no lipid emulsions
Number of subjects: 90
Study: 35676697

Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints with lower pain threshold (LPT group)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: Acupuncture at acupoints with higher pain threshold (HPT group)
Number of subjects: 666

Group type: COMPARATOR
Intervention: Waiting-list group (no acupuncture)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: LPT group and HPT group
Number of subjects: 666
Study: 34395335

Group type: EXPERIMENTAL
Intervention: Bone marrow mesenchymal stem cells (BM-MSC) - 5 infusions of 1×10^6 cells/kg for 3 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Standard medical therapy (SMT) plus placebo infusion of saline
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Bone marrow mesenchymal stem cells (BM-MSC)
Number of subjects: 9
Study: 34269121

Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 55447

Group type: COMPARATOR
Intervention: tPA administration
Number of subjects: 55447

Group type: COMPARATOR
Intervention: Decompressive hemicraniectomy (DHC)
Number of subjects: 55447

Group type: COMPARATOR
Intervention: Total stroke admissions
Number of subjects: 55447
Study: 33401473

Group type: EXPERIMENTAL
Intervention: 12-week resistance training + protein supplementation (RT + PRO)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 39
Study: 36177452

Group type: EXPERIMENTAL
Intervention: 60-s delay in cord clamping (60-s DCC)
Number of subjects: 123

Group type: COMPARATOR
Intervention: PBCC, 30-s DCC, and I-UCM
Number of subjects: 123

Group type: COMPARATOR
Intervention: I-UCM, 60-s DCC, and 30-s DCC
Number of subjects: 123
Study: 32804268

Group type: EXPERIMENTAL
Intervention: Pulmonary recruitment maneuver (PRM)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Intraperitoneal anesthetic instillation (IAI)
Number of subjects: 84
Study: 34773995

Group type: EXPERIMENTAL
Intervention: Low concentration popliteal-sciatic nerve block (SNB) with 0.125% bupivacaine [20 ml] and dexamethasone [5 mg]
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (adductor canal blocks and periarticular infiltration without SNB)
Number of subjects: 50
Study: 33346848

Group type: EXPERIMENTAL
Intervention: Fecal microbiome transfer (FMT)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 34962979

Group type: EXPERIMENTAL
Intervention: Edoxaban 60/30 mg
Number of subjects: 841

Group type: EXPERIMENTAL
Intervention: Edoxaban 30/15 mg
Number of subjects: 841

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 841
Study: 34788550

Group type: EXPERIMENTAL
Intervention: Green Tea Extract (GTE) 400 mg every 12 hours for 3 months
Number of subjects: 39
Study: 33564423

Group type: EXPERIMENTAL
Intervention: Linagliptin (LINA) 5mg
Number of subjects: 6979

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 6979
Study: 32134490

Group type: EXPERIMENTAL
Intervention: CMV prevention interventions (specifics not provided)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (specifics not provided)
Number of subjects: 0
Study: 35522352

Group type: EXPERIMENTAL
Intervention: Ostomy Self‐Management Training program (OSMT) with goal setting
Number of subjects: 524

Group type: COMPARATOR
Intervention: Usual care (UC) without goal setting
Number of subjects: 524
Study: 34324636

Group type: EXPERIMENTAL
Intervention: Seltorexant 20 mg
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 32117519

Group type: EXPERIMENTAL
Intervention: Flutter bag drainage device
Number of subjects: 41

Group type: COMPARATOR
Intervention: Underwater seal drainage bottle
Number of subjects: 41
Study: 32964238

Group type: EXPERIMENTAL
Intervention: Ustekinumab (UST)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vedolizumab (VDZ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of ileal pyroptosis <14 positive cells/1000 IECs or MVL of 1.35 to 1.55 µm
Number of subjects: 0
Study: 33038249

Group type: EXPERIMENTAL
Intervention: BIT225 100 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: BIT225 200 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 34321182

Group type: EXPERIMENTAL
Intervention: Early Mobilisation (EM)
Number of subjects: 16
Study: 32735029

Group type: EXPERIMENTAL
Intervention: MCP (ondansetron + DEX on day 1 + metoclopramide on days 2–3)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: PAL (palonosetron + DEX on day 1)
Number of subjects: 189

Group type: COMPARATOR
Intervention: DEX (ondansetron on day 1 + DEX on days 1–3)
Number of subjects: 189
Study: 35588970

Group type: EXPERIMENTAL
Intervention: Rapid phenotypic antibiotic susceptibility testing (AST) with antimicrobial stewardship programme (ASP)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional AST
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Rapid phenotypic AST with ASP
Number of subjects: 116
Study: 33745285

Group type: EXPERIMENTAL
Intervention: Brief interpersonal psychotherapy (IPT-B)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Enhanced maternity support services (MSS-Plus)
Number of subjects: 16
Study: 32275366

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Medication (Metformin, 500 mg twice a day)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Medication (Metformin)
Number of subjects: 70
Study: 35443967

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) technology
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control (no VR)
Number of subjects: 117
Study: 32721189

Group type: EXPERIMENTAL
Intervention: Preferred music genre (PMG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-preferred music genre (NPMG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No music (NM)
Number of subjects: 20
Study: 35603666

Group type: EXPERIMENTAL
Intervention: 5-minute cognitive assessment coupled with an electronic medical record-embedded decision tree
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Current cognitive assessment paradigms in primary care
Number of subjects: 1200
Study: 33601996

Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Baseline PFT
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Lake Louise Questionnaire
Number of subjects: 103
Study: 33667960

Group type: EXPERIMENTAL
Intervention: AH with miruco group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional AH home exercise
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (wait-and-see approach)
Number of subjects: 60
Study: 32709051

Group type: EXPERIMENTAL
Intervention: Inorganic nitrate (beetroot juice)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Nitrate‐depleted placebo
Number of subjects: 5
Study: 35358207

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding (EBF) between 3 and 6 months
Number of subjects: 570
Study: 32693859

Group type: EXPERIMENTAL
Intervention: Short Food Frequency Questionnaire (SFFQ)
Number of subjects: 99
Study: 33361337

Group type: EXPERIMENTAL
Intervention: Triplet therapy (pembrolizumab 200 mg IV every 3 weeks + dabrafenib 150 mg orally twice daily + trametinib 2 mg orally once daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Doublet therapy (placebo + dabrafenib 150 mg orally twice daily + trametinib 2 mg orally once daily)
Number of subjects: 120
Study: 35337268

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Peripheral nerve block anaesthesia (PNBA)
Number of subjects: 40
Study: 33196078

Group type: EXPERIMENTAL
Intervention: Sleep onset consistency
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Diet quality
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Household poverty
Number of subjects: 207
Study: 32034789

Group type: EXPERIMENTAL
Intervention: Ca(OH)2 + Ciprofloxacin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ca(OH)2
Number of subjects: 45

Group type: COMPARATOR
Intervention: Ca(OH)2 + Ibuprofen
Number of subjects: 45
Study: 33901811

Group type: EXPERIMENTAL
Intervention: Various interventions related to symptomology and quality of life
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Various biomedical topics
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Co-morbidities
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Non-pharmacological management
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Aetiologies
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Pharmacological management
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Clinical management
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Observational designs
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Experimental designs
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Duration of effect
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Subjective measurement tools
Number of subjects: 779
Study: 34044675

Group type: COMPARATOR
Intervention: miRNA expression profile in B lymphocytes from wAIHA patients
Number of subjects: 12

Group type: COMPARATOR
Intervention: stem‐loop qRT‐PCR verification of miRNA sequencing results
Number of subjects: 12

Group type: COMPARATOR
Intervention: GO functional enrichment and pathway enrichment analyses
Number of subjects: 12

Group type: COMPARATOR
Intervention: Differentially expressed miRNAs
Number of subjects: 12
Study: 32978042

Group type: EXPERIMENTAL
Intervention: 4 5‐min cycle protocol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 75/5 mmHg protocol
Number of subjects: 20
Study: 35086735

Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg with acid suppression therapy
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Plecanatide 6 mg with acid suppression therapy
Number of subjects: 2639

Group type: COMPARATOR
Intervention: Placebo with acid suppression therapy
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Plecanatide 3 mg without acid suppression therapy
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Plecanatide 6 mg without acid suppression therapy
Number of subjects: 2639

Group type: COMPARATOR
Intervention: Placebo without acid suppression therapy
Number of subjects: 2639

Group type: EXPERIMENTAL
Intervention: Concomitant acid suppression therapy
Number of subjects: 2639

Group type: COMPARATOR
Intervention: No acid suppression therapy
Number of subjects: 2639
Study: 34918660

Group type: EXPERIMENTAL
Intervention: Educational digital storytelling intervention
Number of subjects: 84

Group type: COMPARATOR
Intervention: No-intervention control group
Number of subjects: 84
Study: 36364705

Group type: EXPERIMENTAL
Intervention: Even dietary protein distribution (EVEN, n = 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Skewed dietary protein distribution (SKEWED, n = 12)
Number of subjects: 24
Study: 32660919

Group type: EXPERIMENTAL
Intervention: Directed manipulation at the most painful lumbar level
Number of subjects: 148

Group type: COMPARATOR
Intervention: Generic manipulation of the spine (control group)
Number of subjects: 148
Study: 36046011

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided right-sided stellate ganglion block with 6 ml 0.25% ropivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: No block (control group)
Number of subjects: 60
Study: 33745818

Group type: EXPERIMENTAL
Intervention: Prevention research awards
Number of subjects: 14523

Group type: EXPERIMENTAL
Intervention: Analysis of existing data
Number of subjects: 14523

Group type: EXPERIMENTAL
Intervention: Randomized interventions
Number of subjects: 14523

Group type: EXPERIMENTAL
Intervention: Randomized interventions addressing leading risk factors in minority health
Number of subjects: 14523
Study: 32052503

Group type: EXPERIMENTAL
Intervention: PEG‐IFN monotherapy (n=136)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: PEG‐IFN and lamivudine (n=130)
Number of subjects: 266

Group type: COMPARATOR
Intervention: PEG‐IFN monotherapy and PEG‐IFN and lamivudine
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: HBV RNA level above 5.5 log c/mL at week 12
Number of subjects: 266
Study: 35835531

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided laparoscopic ovarian cystectomy (UGLOC)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Laparoscopic ovarian cystectomy (gold standard treatment)
Number of subjects: 94
Study: 33843552

Group type: EXPERIMENTAL
Intervention: Online food composition database developed for 148 commonly consumed foods
Number of subjects: 74

Group type: COMPARATOR
Intervention: Comparison with existing databases
Number of subjects: 74
Study: 35167388

Group type: EXPERIMENTAL
Intervention: Feminist norm condition
Number of subjects: 291

Group type: EXPERIMENTAL
Intervention: Traditional feminine norm condition
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control norm condition
Number of subjects: 291
Study: 33737170

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral stress management (CBSM)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Health promotion (control)
Number of subjects: 192
Study: 34547623

Group type: EXPERIMENTAL
Intervention: Basal diet with 200 mg/kg LYC
Number of subjects: 192

Group type: COMPARATOR
Intervention: Basal diet with 100 �g/kg AFB1
Number of subjects: 192
Study: 35136915

Group type: EXPERIMENTAL
Intervention: Omega-3 supplementation (1 g/day)
Number of subjects: 2157

Group type: COMPARATOR
Intervention: Vitamin D supplementation (2000 IU/day)
Number of subjects: 2157

Group type: COMPARATOR
Intervention: Simple home exercise program (SHEP)
Number of subjects: 2157
Study: 34022930

Group type: EXPERIMENTAL
Intervention: Single-session videoconference-delivered group pain education class
Number of subjects: 120

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 120
Study: 35594344

Group type: EXPERIMENTAL
Intervention: 8-week mindfulness-based stress reduction (MBSR) program (n = 75)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Validated, matched active control (n = 73)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Waitlist control (WL) (n = 70)
Number of subjects: 218
Study: 33180688

Group type: EXPERIMENTAL
Intervention: Community-Based Participatory Research (CBPR) RCTs
Number of subjects: 0
Study: 35299154

Group type: EXPERIMENTAL
Intervention: SLOW group (n = 11) at inclines up to 4%
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: FAST group (n = 22) at inclines at or above 6%
Number of subjects: 33

Group type: COMPARATOR
Intervention: ACSM VO2 prediction
Number of subjects: 33
Study: 33677157

Group type: EXPERIMENTAL
Intervention: real rTMS
Number of subjects: 50

Group type: COMPARATOR
Intervention: sham rTMS
Number of subjects: 50
Study: 34508295

Group type: EXPERIMENTAL
Intervention: Nilotinib 300 mg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imatinib 400 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 0
Study: 33845863

Group type: EXPERIMENTAL
Intervention: Optimized quality improvement (QI) initiatives
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 24
Study: 36270754

Group type: EXPERIMENTAL
Intervention: Extended-release injectable buprenorphine (BUP-XR)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sublingual buprenorphine (BUP-SL)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral liquid methadone (MET)
Number of subjects: 120
Study: 34812466

Group type: EXPERIMENTAL
Intervention: 50 g of freeze-dried strawberry powder (FDSP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25 g FDSP + 25 g of placebo powder
Number of subjects: 0

Group type: COMPARATOR
Intervention: 50 g placebo powder
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 g FDSP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25 g FDSP
Number of subjects: 0
Study: 32508323

Group type: COMPARATOR
Intervention: donepezil + placebo (D + P)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: donepezil + choline alphoscerate (D + CA)
Number of subjects: 56
Study: 35579484

Group type: EXPERIMENTAL
Intervention: Suvorexant (20 or 15 mg/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Eszopiclone (3 or 2 mg/d)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Suvorexant or Eszopiclone
Number of subjects: 18
Study: 35002810

Group type: EXPERIMENTAL
Intervention: Immediate treatment group (n = 28)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Delayed treatment group (n = 26)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Both groups pooled
Number of subjects: 54
Study: 33260076

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 20
Study: 35014578

Group type: EXPERIMENTAL
Intervention: Mental imagery intervention
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Baseline adherence (T1)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Being male
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for non-adherents
Number of subjects: 297
Study: 33206268

Group type: EXPERIMENTAL
Intervention: Kata techniques training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Aquatic training
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 32538267

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Inert pill
Number of subjects: 30
Study: 33662512

Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study: 33247023

Group type: EXPERIMENTAL
Intervention: Web-based psychosocial peer-to-peer support intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 35940831

Group type: EXPERIMENTAL
Intervention: PEN-FAST score-guided management with direct oral penicillin challenge
Number of subjects: 380

Group type: COMPARATOR
Intervention: Standard care (skin testing followed by oral penicillin challenge if skin testing is negative)
Number of subjects: 380
Study: 34535164

Group type: EXPERIMENTAL
Intervention: Skin contact combined with mother’s breastfeeding model
Number of subjects: 148

Group type: COMPARATOR
Intervention: Routine pacifier sucking training model
Number of subjects: 148
Study: 32572223

Group type: EXPERIMENTAL
Intervention: Ruminococcus and rs150018970 near RAPGEF1 on chromosome 9; P = 1.57 × 10−10
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Coprococcus and rs561177583 within LINC01787 on chromosome 1; P = 1.57 × 10−10
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Bifidobacterium and rs4988235 (MCM6/LCT); P < 2.5 × 10−8
Number of subjects: 2940

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analysis for microbial traits and disease; Caution advised in interpretation due to unclear microbiome-driven effects.
Number of subjects: 2940
Study: 35832541

Group type: EXPERIMENTAL
Intervention: Cetuximab + Avelumab
Number of subjects: 173

Group type: COMPARATOR
Intervention: Cetuximab (single agent)
Number of subjects: 173
Study: 33602643

Group type: EXPERIMENTAL
Intervention: Secretin
Number of subjects: 170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 170
Study: 33433595

Group type: EXPERIMENTAL
Intervention: HEAL-enrolled parents
Number of subjects: 269

Group type: COMPARATOR
Intervention: HEAL-declined parents
Number of subjects: 269

Group type: COMPARATOR
Intervention: Black parents
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Parents reporting serious infant medical condition
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Parents who enrolled their infant
Number of subjects: 269

Group type: COMPARATOR
Intervention: Study comprehension
Number of subjects: 269
Study: 35924663

Group type: EXPERIMENTAL
Intervention: SC + 5 EVs (audio-visual educational videos)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Usual standard care (SC)
Number of subjects: 195
Study: 33270577

Group type: EXPERIMENTAL
Intervention: Focused low-intensity shock-wave therapy and androgen-stimulation therapy (MG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (CG) - Androgen-stimulation therapy only
Number of subjects: 42
Study: 35287133

Group type: EXPERIMENTAL
Intervention: Mentalizing Imagery Therapy (MIT)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Support Group (SG)
Number of subjects: 46
Study: 33187543

Group type: EXPERIMENTAL
Intervention: XBYRT (Traditional Chinese Medicine herbal decoction)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo decoction
Number of subjects: 80
Study: 32356007

Group type: EXPERIMENTAL
Intervention: TXA 250 mg once daily
Number of subjects: 132

Group type: COMPARATOR
Intervention: TXA 500 mg twice daily
Number of subjects: 132